Platelets at work in primary hemostasis

Blood Reviews

Volumn 25, Issue 4, 2011, Pages 155-167

  Broos, Katleen ^a   Feys, Hendrik B ^a   De Meyer, Simon F ^a   Vanhoorelbeke, Karen ^a   Deckmyn, Hans ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Activation; Platelet adhesion; Secretion and aggregation; Signal transduction

Indexed keywords

ADENYLATE CYCLASE; BETA1 INTEGRIN; BETA3 INTEGRIN; CALCIUM ION; COLLAGEN; COLLAGEN RECEPTOR; COLLAGEN RECEPTOR ALPHA2BETA1; DIACYLGLYCEROL; FC RECEPTOR; FC RECEPTOR GAMMA; FIBRONECTIN; G PROTEIN COUPLED RECEPTOR; GLYCOPROTEIN IB ALPHA; GLYCOPROTEIN VI; LAMININ; MYOSIN LIGHT CHAIN; PHOSPHATIDYLSERINE; PHOSPHOLIPASE C GAMMA2; PROTEIN KINASE FYN; PROTEIN KINASE LYN; PROTEINASE ACTIVATED RECEPTOR 1; PROTEINASE ACTIVATED RECEPTOR 4; RAP1 PROTEIN; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; STROMAL INTERACTION MOLECULE 1; THROMBOCYTE RECEPTOR; THROMBOXANE A2; THROMBOXANE A2 RECEPTOR; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR;

AMINO TERMINAL SEQUENCE; ARTICLE; BINDING AFFINITY; BLOOD VESSEL INJURY; BLOOD VESSEL WALL; CALCIUM MOBILIZATION; CALCIUM TRANSPORT; CELL GRANULE; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; HEMOSTASIS; HUMAN; LYSOSOME; NONHUMAN; PLATELET ALPHA GRANULE; PLATELET DENSE GRANULE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN IMMOBILIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RECEPTOR OCCUPANCY; SHEAR RATE; SIGNAL TRANSDUCTION; SUBENDOTHELIUM; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; THROMBOCYTE MEMBRANE; THROMBOGENESIS; VASCULAR ENDOTHELIUM;

ANIMALS; BLOOD PLATELETS; ENDOTHELIUM, VASCULAR; HEMOSTASIS; HUMANS; PLATELET ACTIVATION; PLATELET ADHESIVENESS; PLATELET AGGREGATION; SIGNAL TRANSDUCTION;

EID: 79957975320     PISSN: 0268960X     EISSN: 15321681     Source Type: Journal    
DOI: 10.1016/j.blre.2011.03.002     Document Type: Article

References (247)

1. Leslie M. Cell biology. Beyond clotting: the powers of platelets. Science 2010, 328:562-564.
2. Farndale RW, Siljander PR, Onley DJ, Sundaresan P, Knight CG, Barnes MJ. Collagen-platelet interactions: recognition and signalling. Biochem. Soc. Symp. 200381-94.
3. De Meyer S.F., Deckmyn H., Vanhoorelbeke K. von Willebrand factor to the rescue. Blood 2009, 113:5049-5057.
4. Lankhof H., van Hoeij M., Schiphorst M.E., Bracke M., Wu Y.P., Ijsseldijk M.J., et al. A3 domain is essential for interaction of von Willebrand factor with collagen type III. Thromb Haemost 1996, 75:950-958.
5. Hoylaerts M.F., Yamamoto H., Nuyts K., Vreys I., Deckmyn H., Vermylen J. von Willebrand factor binds to native collagen VI primarily via its A1 domain. Biochem J 1997, 324(Pt 1):185-191.
6. Savage B., Sixma J.J., Ruggeri Z.M. Functional self-association of von Willebrand factor during platelet adhesion under flow. Proc Nat Acad Sci USA 2002, 99:425-430.
7. Dayananda K.M., Singh I., Mondal N., Neelamegham S. von Willebrand factor self-association on platelet GpIb{alpha} under hydrodynamic shear: effect on shear-induced platelet activation. Blood 2010, 116:3990-3998.
8. Ulrichts H., Vanhoorelbeke K., Girma J.P., Lenting P.J., Vauterin S., Deckmyn H. The von Willebrand factor self-association is modulated by a multiple domain interaction. J Thromb Haemost 2005, 3:552-561.
9. Andrews R.K., Gardiner E.E., Shen Y., Whisstock J.C., Berndt M.C. Glycoprotein Ib-IX-V. Int J Biochem Cell Biol 2003, 35:1170-1174.
10. Martin C., Morales L.D., Cruz M.A. Purified A2 domain of von Willebrand factor binds to the active conformation of von Willebrand factor and blocks the interaction with platelet glycoprotein Ibalpha. J Thromb Haemost 2007, 5:1363-1370.
11. Nishio K., Anderson P.J., Zheng X.L., Sadler J.E. Binding of platelet glycoprotein Ibalpha to von Willebrand factor domain A1 stimulates the cleavage of the adjacent domain A2 by ADAMTS13. Proc Nat Acad Sci USA 2004, 101:10578-10583.
12. Ulrichts H., Udvardy M., Lenting P.J., Pareyn I., Vandeputte N., Vanhoorelbeke K., et al. Shielding of the A1 domain by the D'D3 domains of von Willebrand factor modulates its interaction with platelet glycoprotein Ib-IX-V. J Biol Chem 2006, 281:4699-4707.
13. Kim J., Zhang C.Z., Zhang X., Springer T.A. A mechanically stabilized receptor-ligand flex-bond important in the vasculature. Nature 2010, 466:992-995.
14. Yago T., Lou J., Wu T., Yang J., Miner J.J., Coburn L., et al. Platelet glycoprotein Ibalpha forms catch bonds with human WT vWF but not with type 2B von Willebrand disease vWF. J Clin Invest 2008, 118:3195-3207.
15. Ruggeri Z.M., Orje J.N., Habermann R., Federici A.B., Reininger A.J. Activation-independent platelet adhesion and aggregation under elevated shear stress. Blood 2006, 108:1903-1910.
16. Salles I.I., Feys H.B., Iserbyt B.F., De Meyer S.F., Vanhoorelbeke K., Deckmyn H. Inherited traits affecting platelet function. Blood Rev 2008, 22:155-172.
17. Ware J., Russell S., Ruggeri Z.M. Generation and rescue of a murine model of platelet dysfunction: the Bernard-Soulier syndrome. Proc Nat Acad Sci USA 2000, 97:2803-2808.
18. Kato K., Martinez C., Russell S., Nurden P., Nurden A., Fiering S., et al. Genetic deletion of mouse platelet glycoprotein Ibbeta produces a Bernard-Soulier phenotype with increased alpha-granule size. Blood 2004, 104:2339-2344.
19. Bergmeier W., Piffath C.L., Goerge T., Cifuni S.M., Ruggeri Z.M., Ware J., et al. The role of platelet adhesion receptor GPIbalpha far exceeds that of its main ligand, von Willebrand factor, in arterial thrombosis. Proc Nat Acad Sci USA 2006, 103:16900-16905.
20. Denis C., Methia N., Frenette P.S., Rayburn H., Ullman-Cullere M., Hynes R.O., et al. A mouse model of severe von Willebrand disease: defects in hemostasis and thrombosis. Proc Nat Acad Sci USA 1998, 95:9524-9529.
21. Ni H., Denis C.V., Subbarao S., Degen J.L., Sato T.N., Hynes R.O., et al. Persistence of platelet thrombus formation in arterioles of mice lacking both von Willebrand factor and fibrinogen. J Clin Invest 2000, 106:385-392.
22. Jurk K., Clemetson K.J., de Groot P.G., Brodde M.F., Steiner M., Savion N., et al. Thrombospondin-1 mediates platelet adhesion at high shear via glycoprotein Ib (GPIb): an alternative/backup mechanism to von Willebrand factor. FASEB J 2003, 17:1490-1492.
23. Nieswandt B., Watson S.P. Platelet-collagen interaction: is GPVI the central receptor?. Blood 2003, 102:449-461.
24. Nieuwenhuis H.K., Akkerman J.W., Houdijk W.P., Sixma J.J. Human blood platelets showing no response to collagen fail to express surface glycoprotein Ia. Nature 1985, 318:470-472.
25. Kehrel B., Balleisen L., Kokott R., Mesters R., Stenzinger W., Clemetson K.J., et al. Deficiency of intact thrombospondin and membrane glycoprotein Ia in platelets with defective collagen-induced aggregation and spontaneous loss of disorder. Blood 1988, 71:1074-1078.
26. Moroi M., Jung S.M., Okuma M., Shinmyozu K. A patient with platelets deficient in glycoprotein VI that lack both collagen-induced aggregation and adhesion. J Clin Invest 1989, 84:1440-1445.
27. Boylan B., Chen H., Rathore V., Paddock C., Salacz M., Friedman K.D., et al. Anti-GPVI-associated ITP: an acquired platelet disorder caused by autoantibody-mediated clearance of the GPVI/FcRgamma-chain complex from the human platelet surface. Blood 2004, 104:1350-1355.
28. Dumont B., Lasne D., Rothschild C., Bouabdelli M., Ollivier V., Oudin C., et al. Absence of collagen-induced platelet activation caused by compound heterozygous GPVI mutations. Blood 2009, 114:1900-1903.
29. Akiyama M., Kashiwagi H., Todo K., Moroi M., Berndt M.C., Kojima H., et al. Presence of platelet-associated anti-glycoprotein (GP)VI autoantibodies and restoration of GPVI expression in patients with GPVI deficiency. J Thromb Haemost 2009, 7:1373-1383.
30. Jung S.M., Moroi M. Platelet glycoprotein VI. Adv Exp Med Biol 2008, 640:53-63.
31. Moroi M., Jung S.M. Platelet glycoprotein VI: its structure and function. Thromb Res 2004, 114:221-233.
32. Berlanga O., Bori-Sanz T., James J.R., Frampton J., Davis S.J., Tomlinson M.G., et al. Glycoprotein VI oligomerization in cell lines and platelets. J Thromb Haemost 2007, 5:1026-1033.
33. Arthur J.F., Shen Y., Kahn M.L., Berndt M.C., Andrews R.K., Gardiner E.E. Ligand binding rapidly induces disulfide-dependent dimerization of glycoprotein VI on the platelet plasma membrane. J Biol Chem 2007, 282:30434-30441.
34. Jung S.M., Tsuji K., Moroi M. Glycoprotein (GP) VI dimer as a major collagen-binding site of native platelets: direct evidence obtained with dimeric GPVI-specific Fabs. J Thromb Haemost 2009, 7:1347-1355.
35. Knight C.G., Morton L.F., Onley D.J., Peachey A.R., Ichinohe T., Okuma M., et al. Collagen-platelet interaction: Gly-Pro-Hyp is uniquely specific for platelet Gp VI and mediates platelet activation by collagen. Cardiovasc Res 1999, 41:450-457.
36. Jarvis G.E., Raynal N., Langford J.P., Onley D.J., Andrews A., Smethurst P.A., et al. Identification of a major GpVI-binding locus in human type III collagen. Blood 2008, 111:4986-4996.
37. Smethurst P.A., Onley D.J., Jarvis G.E., O'Connor M.N., Knight C.G., Herr A.B., et al. Structural basis for the platelet-collagen interaction: the smallest motif within collagen that recognizes and activates platelet Glycoprotein VI contains two glycine-proline-hydroxyproline triplets. J Biol Chem 2007, 282:1296-1304.
38. Pugh N., Simpson A.M., Smethurst P.A., de Groot P.G., Raynal N., Farndale R.W. Synergism between platelet collagen receptors defined using receptor-specific collagen-mimetic peptide substrata in flowing blood. Blood 2010, 115:5069-5079.
39. Schulz C., Leuschen N.V., Frohlich T., Lorenz M., Pfeiler S., Gleissner C.A., et al. Identification of novel downstream targets of platelet glycoprotein VI activation by differential proteome analysis: implications for thrombus formation. Blood 2010, 115:4102-4110.
40. Lockyer S., Okuyama K., Begum S., Le S., Sun B., Watanabe T., et al. GPVI-deficient mice lack collagen responses and are protected against experimentally induced pulmonary thromboembolism. Thromb Res 2006, 118:371-380.
41. Konishi H., Katoh Y., Takaya N., Kashiwakura Y., Itoh S., Ra C., et al. Platelets activated by collagen through immunoreceptor tyrosine-based activation motif play pivotal role in initiation and generation of neointimal hyperplasia after vascular injury. Circulation 2002, 105:912-916.
42. Massberg S., Gawaz M., Gruner S., Schulte V., Konrad I., Zohlnhofer D., et al. A crucial role of glycoprotein VI for platelet recruitment to the injured arterial wall in vivo. J Exp Med 2003, 197:41-49.
43. Nieswandt B., Schulte V., Bergmeier W., Mokhtari-Nejad R., Rackebrandt K., Cazenave J.P., et al. Long-term antithrombotic protection by in vivo depletion of platelet glycoprotein VI in mice. J Exp Med 2001, 193:459-469.
44. Dubois C., Panicot-Dubois L., Merrill-Skoloff G., Furie B., Furie B.C. Glycoprotein VI-dependent and -independent pathways of thrombus formation in vivo. Blood 2006, 107:3902-3906.
45. Konstantinides S., Ware J., Marchese P., mus-Jacobs F., Loskutoff D.J., Ruggeri Z.M. Distinct antithrombotic consequences of platelet glycoprotein Ibalpha and VI deficiency in a mouse model of arterial thrombosis. J Thromb Haemost 2006, (4):2014-2021.
46. Emsley J., Knight C.G., Farndale R.W., Barnes M.J., Liddington R.C. Structural basis of collagen recognition by integrin alpha2beta1. Cell 2000, 101:47-56.
47. Van de Walle G.R., Vanhoorelbeke K., Majer Z., Illyes E., Baert J., Pareyn I., et al. Two functional active conformations of the integrin {alpha}2{beta}1, depending on activation condition and cell type. J Biol Chem 2005, 280:36873-36882.
48. Jung S.M., Moroi M. Platelet collagen receptor integrin alpha2beta1 activation involves differential participation of ADP-receptor subtypes P2Y1 and P2Y12 but not intracellular calcium change. Eur J Biochem 2001, 268:3513-3522.
49. Jung S.M., Moroi M. Signal-transducing mechanisms involved in activation of the platelet collagen receptor integrin alpha(2)beta(1). J Biol Chem 2000, 275:8016-8026.
50. Nieswandt B., Brakebusch C., Bergmeier W., Schulte V., Bouvard D., Mokhtari-Nejad R., et al. Glycoprotein VI but not alpha2beta1 integrin is essential for platelet interaction with collagen. EMBO J 2001, 20:2120-2130.
51. Van de Walle G.R., Schoolmeester A., Iserbyt B.F., Cosemans J.M., Heemskerk J.W., Hoylaerts M.F., et al. Activation of alphaIIbbeta3 is a sufficient but also an imperative prerequisite for activation of alpha2beta1 on platelets. Blood 2007, 109:595-602.
52. Atkinson B.T., Jarvis G.E., Watson S.P. Activation of GPVI by collagen is regulated by alpha2beta1 and secondary mediators. J Thromb Haemost 2003, 1:1278-1287.
53. Bernardi B., Guidetti G.F., Campus F., Crittenden J.R., Graybiel A.M., Balduini C., et al. The small GTPase Rap1b regulates the cross talk between platelet integrin alpha2beta1 and integrin alphaIIbbeta3. Blood 2006, 107:2728-2735.
54. Chen H., Kahn M.L. Reciprocal signaling by integrin and nonintegrin receptors during collagen activation of platelets. Mol Cell Biol 2003, 23:4764-4777.
55. Siljander P.R.M., Munnix I.C.A., Smethurst P.A., Deckmyn H., Lindhout T., Ouwehand W.H., et al. Platelet receptor interplay regulates collagen-induced thrombus formation in flowing human blood. Blood 2004, 103:1333-1341.
56. Gruner S., Prostredna M., Schulte V., Krieg T., Eckes B., Brakebusch C., et al. Multiple integrin-ligand interactions synergize in shear-resistant platelet adhesion at sites of arterial injury in vivo. Blood 2003, 102:4021-4027.
57. He L., Pappan L.K., Grenache D.G., Li Z.Z., Tollefsen D.M., Santoro S.A., et al. The contributions of the alpha(2)beta(1) integrin to vascular thrombosis in vivo. Blood 2003, 102:3652-3657.
58. Holtkotter O., Nieswandt B., Smyth N., Muller W., Hafner M., Schulte V., et al. Integrin alpha 2-deficient mice develop normally, are fertile, but display partially defective platelet interaction with collagen. J Biol Chem 2002, 277:10789-10794.
59. Kuijpers M.J., Pozgajova M., Cosemans J.M., Munnix I.C., Eckes B., Nieswandt B., et al. Role of murine integrin alpha2beta1 in thrombus stabilization and embolization: contribution of thromboxane A2. Thromb Haemost 2007, 98:1072-1080.
60. Savage B., Saldivar E., Ruggeri Z.M. Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor. Cell 1996, 84:289-297.
61. Ruggeri Z.M., Mendolicchio G.L. Adhesion mechanisms in platelet function. Circ Res 2007, 100:1673-1685.
62. Du X. Signaling and regulation of the platelet glycoprotein Ib-IX-V complex. Curr Opin Hematol 2007, 14:262-269.
63. Cosemans J.M., Van K.R., Olieslagers S., Schurgers L.J., Verheyen F.K., Munnix I.C., et al. Potentiating role of Gas6 and Tyro3, Axl and Mer (TAM) receptors in human and murine platelet activation and thrombus stabilization. J Thromb Haemost 2010, 8:1797-1808.
64. Watson S.P., Herbert J.M., Pollitt A.Y. GPVI and CLEC-2 in hemostasis and vascular integrity. J Thromb Haemost 2010, 8:1456-1467.
65. Suzuki-Inoue K., Kato Y., Inoue O., Kaneko M.K., Mishima K., Yatomi Y., et al. Involvement of the snake toxin receptor CLEC-2, in podoplanin-mediated platelet activation, by cancer cells. J Biol Chem 2007, 282:25993-26001.
66. Cueni L.N., Chen L., Zhang H., Marino D., Huggenberger R., Alitalo A., et al. Podoplanin-Fc reduces lymphatic vessel formation in vitro and in vivo and causes disseminated intravascular coagulation when transgenically expressed in the skin. Blood 2010, 116:4376-4384.
67. Lee F.A., van L.M., Relou I.A., Foley L., Akkerman J.W., Heijnen H.F., et al. Lipid rafts facilitate the interaction of PECAM-1 with the glycoprotein VI-FcR gamma-chain complex in human platelets. J Biol Chem 2006, 281:39330-39338.
68. Varga-Szabo D., Braun A., Nieswandt B. Calcium signaling in platelets. J Thromb Haemost 2009, 7:1057-1066.
69. Bergmeier W., Stefanini L. Novel molecules in calcium signaling in platelets. J Thromb Haemost 2009, 7(Suppl. 1):187-190.
70. Bobe R., Bredoux R., Corvazier E., Lacabaratz-Porret C., Martin V., Kovacs T., et al. How many Ca(2)+ ATPase isoforms are expressed in a cell type? A growing family of membrane proteins illustrated by studies in platelets. Platelets 2005, 16:133-150.
71. Freyssinet J.M., Toti F. Formation of procoagulant microparticles and properties. Thromb Res 2010, 125(Suppl. 1):S46-S48.
72. Suzuki J., Umeda M., Sims P.J., Nagata S. Calcium-dependent phospholipid scrambling by TMEM16F. Nature 2010, 468:834-838.
73. Morel O., Morel N., Freyssinet J.M., Toti F. Platelet microparticles and vascular cells interactions: a checkpoint between the haemostatic and thrombotic responses. Platelets 2008, 19:9-23.
74. Kramer R.M., Roberts E.F., Um S.L., Borsch-Haubold A.G., Watson S.P., Fisher M.J., et al. p38 mitogen-activated protein kinase phosphorylates cytosolic phospholipase A2 (cPLA2) in thrombin-stimulated platelets. Evidence that proline-directed phosphorylation is not required for mobilization of arachidonic acid by cPLA2. J Biol Chem 1996, 271:27723-27729.
75. Brass L.F., Manning D.R., Cichowski K., Abrams C.S. Signaling through G proteins in platelets: to the integrins and beyond. Thromb Haemost 1997, 78:581-589.
76. Vu T.K., Hung D.T., Wheaton V.I., Coughlin S.R. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 1991, 64:1057-1068.
77. Ishii K., Chen J., Ishii M., Koch W.J., Freedman N.J., Lefkowitz R.J., et al. Inhibition of thrombin receptor signaling by a G-protein coupled receptor kinase. Functional specificity among G-protein coupled receptor kinases. J Biol Chem 1994, 269:1125-1130.
78. Trejo J., Hammes S.R., Coughlin S.R. Termination of signaling by protease-activated receptor-1 is linked to lysosomal sorting. Proc Natl Acad Sci USA 1998, 95:13698-13702.
79. Molino M., Blanchard N., Belmonte E., Tarver A.P., Abrams C., Hoxie J.A., et al. Proteolysis of the human platelet and endothelial cell thrombin receptor by neutrophil-derived cathepsin G. J Biol Chem 1995, 270:11168-11175.
80. Ludeman M.J., Zheng Y.W., Ishii K., Coughlin S.R. Regulated shedding of PAR1 N-terminal exodomain from endothelial cells. J Biol Chem 2004, 279:18592-18599.
81. Offermanns S. Activation of platelet function through G protein-coupled receptors. Circ Res 2006, 99:1293-1304.
82. Getz T.M., Dangelmaier C.A., Jin J., Daniel J.L., Kunapuli S.P. Differential phosphorylation of myosin light chain (Thr)18 and (Ser)19 and functional implications in platelets. J Thromb Haemost 2010, 8:2283-2293.
83. Gong H., Shen B., Flevaris P., Chow C., Lam S.C., Voyno-Yasenetskaya T.A., et al. G protein subunit Galpha13 binds to integrin alphaIIbbeta3 and mediates integrin "outside-in" signaling. Science 2010, 327:340-343.
84. Cattaneo M. The platelet P2 receptors. Platelets 2006, 201-220. Academic Press, San Diego, CA. A.D. Michelson (Ed.).
85. Garcia A., Kim S., Bhavaraju K., Schoenwaelder S.M., Kunapuli S.P. Role of phosphoinositide 3-kinase beta in platelet aggregation and thromboxane A2 generation mediated by Gi signalling pathways. Biochem J 2010, 429:369-377.
86. Hechler B., Eckly A., Ohlmann P., Cazenave J.P., Gachet C. The P2Y1 receptor, necessary but not sufficient to support full ADP-induced platelet aggregation, is not the target of the drug clopidogrel. Br J Haematol 1998, 103:858-866.
87. Leon C., Hechler B., Freund M., Eckly A., Vial C., Ohlmann P., et al. Defective platelet aggregation and increased resistance to thrombosis in purinergic P2Y(1) receptor-null mice. J Clin Invest 1999, 104:1731-1737.
88. Fabre J.E., Nguyen M., Latour A., Keifer J.A., Audoly L.P., Coffman T.M., et al. Decreased platelet aggregation, increased bleeding time and resistance to thromboembolism in P2Y1-deficient mice. Nat Med 1999, 5:1199-1202.
89. Vinogradova O., Velyvis A., Velyviene A., Hu B., Haas T.A., Plow E.F., et al. A structural mechanism of integrin alpha(IIb)beta(3) "inside-out" activation as regulated by its cytoplasmic face. Cell 2002, 110:587-597.
90. Bergmeier W., Goerge T., Wang H.W., Crittenden J.R., Baldwin A.C., Cifuni S.M., et al. Mice lacking the signaling molecule CalDAG-GEFI represent a model for leukocyte adhesion deficiency type III. J Clin Invest 2007, 117:1699-1707.
91. Crittenden J.R., Bergmeier W., Zhang Y., Piffath C.L., Liang Y., Wagner D.D., et al. CalDAG-GEFI integrates signaling for platelet aggregation and thrombus formation. Nat Med 2004, 10:982-986.
92. Chrzanowska-Wodnicka M., Smyth S.S., Schoenwaelder S.M., Fischer T.H., White G.C. Rap1b is required for normal platelet function and hemostasis in mice. J Clin Invest 2005, 115:680-687.
93. Han J., Lim C.J., Watanabe N., Soriani A., Ratnikov B., Calderwood D.A., et al. Reconstructing and deconstructing agonist-induced activation of integrin alphaIIbbeta3. Curr Biol 2006, 16:1796-1806.
94. Bouaouina M., Lad Y., Calderwood D.A. The N-terminal domains of talin cooperate with the phosphotyrosine binding-like domain to activate beta1 and beta3 integrins. J Biol Chem 2008, 283:6118-6125.
95. Rodius S., Chaloin O., Moes M., Schaffner-Reckinger E., Landrieu I., Lippens G., et al. The talin rod IBS2 alpha-helix interacts with the beta3 integrin cytoplasmic tail membrane-proximal helix by establishing charge complementary salt bridges. J Biol Chem 2008, 283:24212-24223.
96. Banno A., Ginsberg M.H. Integrin activation. Biochem Soc Trans 2008, 36:229-234.
97. Anthis N.J., Wegener K.L., Ye F., Kim C., Goult B.T., Lowe E.D., et al. The structure of an integrin/talin complex reveals the basis of inside-out signal transduction. EMBO J 2009, 28:3623-3632.
98. Shattil S.J., Kim C., Ginsberg M.H. The final steps of integrin activation: the end game. Nat Rev Mol Cell Biol 2010, 11:288-300.
99. Malinin N.L., Zhang L., Choi J., Ciocea A., Razorenova O., Ma Y.Q., et al. A point mutation in KINDLIN3 ablates activation of three integrin subfamilies in humans. Nat Med 2009, 15:313-318.
100. Moser M., Nieswandt B., Ussar S., Pozgajova M., Fassler R. Kindlin-3 is essential for integrin activation and platelet aggregation. Nat Med 2008, 14:325-330.
101. Ma Y.Q., Qin J., Wu C., Plow E.F. Kindlin-2 (Mig-2): a co-activator of beta3 integrins. J Cell Biol 2008, 181:439-446.
102. Reed G.L. Platelet secretory mechanisms. Semin Thromb Hemost 2004, 30:441-450.
103. Maynard D.M., Heijnen H.F., Horne M.K., White J.G., Gahl W.A. Proteomic analysis of platelet alpha-granules using mass spectrometry. J Thromb Haemost 2007, 5:1945-1955.
104. McNicol A., Israels S.J. Platelet dense granules: structure, function and implications for haemostasis. Thromb Res 1999, 95:1-18.
105. Sehgal S., Storrie B. Evidence that differential packaging of the major platelet granule proteins von Willebrand factor and fibrinogen can support their differential release. J Thromb Haemost 2007, 5:2009-2016.
106. Raccuglia G. Gray platelet syndrome. A variety of qualitative platelet disorder. Am J Med 1971, 51:818-828.
107. Gralnick H.R., Williams S.B., McKeown L.P., Krizek D.M., Shafer B.C., Rick M.E. Platelet von Willebrand factor: comparison with plasma von Willebrand factor. Thromb Res 1985, 38:623-633.
108. Du X.P. Signaling and regulation of the platelet glycoprotein Ib-IX-V complex. Curr Opin Hematol 2007, 14:262-269.
109. Ozaki Y., Asazuma N., Suzuki-Inoue K., Berndt M.C. Platelet GPIb-IX-V-dependent signaling. J Thromb Haemost 2005, 3:1745-1751.
110. Coller B.S., Shattil S.J. The GPIIb/IIIa (integrin alpha IIb beta 3) odyssey: a technology-driven saga of a receptor with twists, turns, and even a bend. Blood 2008, 112:3011-3025.
111. Shattil S.J., Newman P.J. Integrins: dynamic scaffolds for adhesion and signaling in platelets. Blood 2004, 104:1606-1615.
112. Jin J.G., Quinton T.M., Zhang J., Rittenhouse S.E., Kunapuli S.P. Adenosine diphosphate (ADP)-induced thromboxane A(2) generation in human platelets requires coordinated signaling through integrin alpha(IIB)beta(3) and ADP receptors. Blood 2002, 99:193-198.
113. Berger G., Masse J.M., Cramer E.M. Alpha-granule membrane mirrors the platelet plasma membrane and contains the glycoproteins Ib, IX, and V. Blood 1996, 87:1385-1395.
114. Suzuki H., Murasaki K., Kodama K., Takayama H. Intracellular localization of glycoprotein VI in human platelets and its surface expression upon activation. Br J Haematol 2003, 121:904-912.
115. Nurden P., Jandrot-Perrus M., Combrie R., Winckler J., Arocas V., Lecut C., et al. Severe deficiency of glycoprotein VI in a patient with gray platelet syndrome. Blood 2004, 104(1):107-114.
116. Fay W.P., Murphy J.G., Owen W.G. High concentrations of active plasminogen activator inhibitor-1 in porcine coronary artery thrombi. Arterioscler Thromb Vasc Biol 1996, 16:1277-1284.
117. Nurden P., Nurden A.T. Congenital disorders associated with platelet dysfunctions. Thromb Haemost 2008, 99:253-263.
118. De C.F., Xhonneux B., Leysen J., Janssen P.A. Evidence for functional 5-HT2 receptor sites on human blood platelets. Biochem Pharmacol 1984, 33:2807-2811.
119. Kahner B.N., Shankar H., Murugappan S., Prasad G.L., Kunapuli S.P. Nucleotide receptor signaling in platelets. J Thromb Haemost 2006, 4:2317-2326.
120. Offermanns S., Toombs C.F., Hu Y.H., Simon M.I. Defective platelet activation in G alpha(q)-deficient mice. Nature 1997, 389:183-186.
121. Simpson A.W.M., Hallam T.J., Rink T.J. Low concentrations of the stable prostaglandin endoperoxide U44069 stimulate shape change in quin2-loaded platelets without a measurable increase in [Ca-2+]i. FEBS Lett 1986, 201:301-305.
122. Suzuki Y., Yamamoto M., Wada H., Ito M., Nakano T., Sasaki Y., et al. Agonist-induced regulation of myosin phosphatase activity in human platelets through activation of Rho-kinase. Blood 1999, 93:3408-3417.
123. Foster C.J., Prosser D.M., Agans J.M., Zhai Y., Smith M.D., Lachowicz J.E., et al. Molecular identification and characterization of the platelet ADP receptor targeted by thienopyridine antithrombotic drugs. J Clin Invest 2001, 107:1591-1598.
124. Konopatskaya O., Gilio K., Harper M.T., Zhao Y., Cosemans J.M., Karim Z.A., et al. PKCalpha regulates platelet granule secretion and thrombus formation in mice. J Clin Invest 2009, 119:399-407.
125. Quinton T.M., Murugappan S., Kim S., Jin J., Kunapuli S.P. Different G protein-coupled signaling pathways are involved in alpha granule release from human platelets. J Thromb Haemost 2004, 2:978-984.
126. Dangelmaier C., Jin J., Smith J.B., Kunapuli S.P. Potentiation of thromboxane A2-induced platelet secretion by Gi signaling through the phosphoinositide-3 kinase pathway. Thromb Haemost 2001, 85:341-348.
127. Hu H., Hoylaerts M.F. The P2X(1) ion channel in platelet function. Platelets 2010, 21:153-166.
128. Vial C., Pitt S.J., Roberts J., Rolf M.G., Mahaut-Smith M.P., Evans R.J. Lack of evidence for functional ADP-activated human P2X(1) receptors supports a role for ATP during hemostasis and thrombosis. Blood 2003, 102:3646-3651.
129. Oury C., Kuijpers M.J., Toth-Zsamboki E., Bonnefoy A., Danloy S., Vreys I., et al. Overexpression of the platelet P2X1 ion channel in transgenic mice generates a novel prothrombotic phenotype. Blood 2003, 101:3969-3976.
130. Rolf M.G., Brearley C.A., Mahaut-Smith M.P. Platelet shape change evoked by selective activation of P2X1 purinoceptors with alpha, beta-methylene ATP. Thromb Haemost 2001, 85:303-308.
131. Muller F., Mutch N.J., Schenk W.A., Smith S.A., Esterl L., Spronk H.M., et al. Platelet polyphosphates are proinflammatory and procoagulant mediators in vivo. Cell 2009, 139:1143-1156.
132. Sehgal S., Storrie B. Evidence that differential packaging of the major platelet granule proteins von Willebrand factor and fibrinogen can support their differential release. J Thromb Haemost 2007, 5:2009-2016.
133. Italiano J.E., Richardson J.L., Patel-Hett S., Battinelli E., Zaslavsky A., Short S., et al. Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet alpha granules and differentially released. Blood 2008, 111:1227-1233.
134. Italiano J.E., Battinelli E.M. Selective sorting of alpha-granule proteins. J Thromb Haemost 2009, 7(Suppl. 1):173-176.
135. Houng A., Polgar J., Reed G.L. Munc18-syntaxin complexes and exocytosis in human platelets. J Biol Chem 2003, 278:19627-19633.
136. Flaumenhaft R. Molecular basis of platelet granule secretion. Arterioscler Thromb Vasc Biol 2003, 23:1152-1160.
137. Chen D., Bernstein A.M., Lemons P.P., Whiteheart S.W. Molecular mechanisms of platelet exocytosis: role of SNAP-23 and syntaxin 2 in dense core granule release. Blood 2000, 95:921-929.
138. Flaumenhaft R., Croce K., Chen E., Furie B., Furie B.C. Proteins of the exocytotic core complex mediate platelet alpha-granule secretion. Roles of vesicle-associated membrane protein, SNAP-23, and syntaxin 4. J Biol Chem 1999, 274:2492-2501.
139. Ren Q., Barber H.K., Crawford G.L., Karim Z.A., Zhao C., Choi W., et al. Endobrevin/VAMP-8 is the primary v-SNARE for the platelet release reaction. Mol Biol Cell 2007, 18:24-33.
140. Graham G.J., Ren Q.S., Dilks J.R., Blair P., Whiteheart S.W., Flaumenhaft R. Endobrevin/VAMP-8-dependent dense granule release mediates thrombus formation in vivo. Blood 2009, 114:1083-1090.
141. Puri N., Roche P.A. Mast cells possess distinct secretory granule subsets whose exocytosis is regulated by different SNARE isoforms. Proc Natl Acad Sci USA 2008, 105:2580-2585.
142. Pannerden H.V.T., de Haas F., Geerts W., Posthuma G., van Dijk S., Heijnen H.F.G. The platelet interior revisited: electron tomography reveals tubular alpha-granule subtypes. Blood 2010, 116:1147-1156.
143. Jackson S.P. The growing complexity of platelet aggregation. Blood 2007, 109:5087-5095.
144. Munnix I.C., Cosemans J.M., Auger J.M., Heemskerk J.W. Platelet response heterogeneity in thrombus formation. Thromb Haemost 2009, 102:1149-1156.
145. Brass L.F., Zhu L., Stalker T.J. Minding the gaps to promote thrombus growth and stability. J Clin Invest 2005, 115:3385-3392.
146. Ruggeri Z.M. Platelet adhesion under flow. Microcirculation 2009, 16:58-83.
147. Luo B.H., Carman C.V., Springer T.A. Structural basis of integrin regulation and signaling. Annu Rev Immunol 2007, 25:619-647.
148. Takagi J., Petre B.M., Walz T., Springer T.A. Global conformational rearrangements in integrin extracellular domains in outside-in and inside-out signaling. Cell 2002, 110:599-611.
149. Savage B., Almus-Jacobs F., Ruggeri Z.M. Specific synergy of multiple substrate-receptor interactions in platelet thrombus formation under flow. Cell 1998, 94:657-666.
150. Ruggeri Z.M. Mechanisms initiating platelet thrombus formation. Thromb Haemost 1997, 78:611-616.
151. Houdijk W.P., Sakariassen K.S., Nievelstein P.F., Sixma J.J. Role of factor VIII-von Willebrand factor and fibronectin in the interaction of platelets in flowing blood with monomeric and fibrillar human collagen types I and III. J Clin Invest 1985, 75:531-540.
152. Brill A., Fuchs T.A., Chauhan A.K., Yang J.J., De Meyer S.F., Kollnberger M., et al. von Willebrand factor-mediated platelet adhesion is critical for deep vein thrombosis in mouse models. Blood 2011, 117:1400-1407.
153. Chauhan A.K., Kisucka J., Lamb C.B., Bergmeier W., Wagner D.D. von Willebrand factor and factor VIII are independently required to form stable occlusive thrombi in injured veins. Blood 2007, 109:2424-2429.
154. Bergmeier W., Chauhan A.K., Wagner D.D. Glycoprotein Ibalpha and von Willebrand factor in primary platelet adhesion and thrombus formation: lessons from mutant mice. Thromb Haemost 2008, 99:264-270.
155. Matuskova J., Chauhan A.K., Cambien B., Astrof S., Dole V.S., Piffath C.L., et al. Decreased plasma fibronectin leads to delayed thrombus growth in injured arterioles. Arterioscler Thromb Vasc Biol 2006, 26:1391-1396.
156. Maxwell M.J., Westein E., Nesbitt W.S., Giuliano S., Dopheide S.M., Jackson S.P. Identification of a 2-stage platelet aggregation process mediating shear-dependent thrombus formation. Blood 2007, 109:566-576.
157. Kulkarni S., Dopheide S.M., Yap C.L., Ravanat C., Freund M., Mangin P., et al. A revised model of platelet aggregation. J Clin Invest 2000, 105:783-791.
158. Dopheide S.M., Maxwell M.J., Jackson S.P. Shear-dependent tether formation during platelet translocation on von Willebrand factor. Blood 2002, 99:159-167.
159. Nesbitt W.S., Westein E., Tovar-Lopez F.J., Tolouei E., Mitchell A., Fu J., et al. A shear gradient-dependent platelet aggregation mechanism drives thrombus formation. Nat Med 2009, 15:665-673.
160. Cosemans J.M., Iserbyt B.F., Deckmyn H., Heemskerk J.W. Multiple ways to switch platelet integrins on and off. J Thromb Haemost 2008, 6:1253-1261.
161. Mazzucato M., Pradella P., Cozzi M.R., De Marco L., Ruggeri Z.M. Sequential cytoplasmic calcium signals in a 2-stage platelet activation process induced by the glycoprotein Ibalpha mechanoreceptor. Blood 2002, 100:2793-2800.
162. Munnix I.C., Cosemans J.M., Auger J.M., Heemskerk J.W. Platelet response heterogeneity in thrombus formation. Thromb Haemost 2009, 102:1149-1156.
163. Nesbitt W.S., Kulkarni S., Giuliano S., Goncalves I., Dopheide S.M., Yap C.L., et al. Distinct glycoprotein Ib/V/IX and integrin alpha IIbbeta 3-dependent calcium signals cooperatively regulate platelet adhesion under flow. J Biol Chem 2002, 277:2965-2972.
164. Ma Y.Q., Qin J., Plow E.F. Platelet integrin alpha(IIb)beta(3): activation mechanisms. J Thromb Haemost 2007, 5:1345-1352.
165. Phillips D.R., Nannizzi-Alaimo L., Prasad K.S. Beta3 tyrosine phosphorylation in alphaIIbbeta3 (platelet membrane GP IIb-IIIa) outside-in integrin signaling. Thromb Haemost 2001, 86:246-258.
166. Hodivala-Dilke K.M., McHugh K.P., Tsakiris D.A., Rayburn H., Crowley D., Ullman-Cullere M., et al. Beta3-integrin-deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival. J Clin Invest 1999, 103:229-238.
167. Suh T.T., Holmback K., Jensen N.J., Daugherty C.C., Small K., Simon D.I., et al. Resolution of spontaneous bleeding events but failure of pregnancy in fibrinogen-deficient mice. Genes Dev 1995, 9:2020-2033.
168. Ni H.Y., Papalia J.M., Degen J.L., Wagner D.D. Control of thrombus embolization and fibronectin internalization by integrin alpha IIb beta 3 engagement of the fibrinogen gamma chain. Blood 2003, 102:3609-3614.
169. Holmback K., Danton M.J., Suh T.T., Daugherty C.C., Degen J.L. Impaired platelet aggregation and sustained bleeding in mice lacking the fibrinogen motif bound by integrin alpha IIb beta 3. EMBO J 1996, 15:5760-5771.
170. Ni H., Yuen P.S., Papalia J.M., Trevithick J.E., Sakai T., Fassler R., et al. Plasma fibronectin promotes thrombus growth and stability in injured arterioles. Proc Natl Acad Sci USA 2003, 100:2415-2419.
171. Angelillo-Scherrer A., Burnier L., Flores N., Savi P., DeMol M., Schaeffer P., et al. Role of Gas6 receptors in platelet signaling during thrombus stabilization and implications for antithrombotic therapy. J Clin Invest 2005, 115:237-246.
172. Angelillo-Scherrer A., de F.P., Aparicio C., Melis E., Savi P., Lupu F., et al. Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosis. Nat Med 2001, 7:215-221.
173. Cosemans J.M., Van K.R., Olieslagers S., Schurgers L.J., Verheyen F.K., Munnix I.C., et al. Potentiating role of Gas6 and Tyro3, Axl and Mer (TAM) receptors in human and murine platelet activation and thrombus stabilization. J Thromb Haemost 2010, 8:1797-1808.
174. Andre P., Prasad K.S., Denis C.V., He M., Papalia J.M., Hynes R.O., et al. CD40L stabilizes arterial thrombi by a beta3 integrin-dependent mechanism. Nat Med 2002, 8:247-252.
175. Chou J., Mackman N., Merrill-Skoloff G., Pedersen B., Furie B.C., Furie B. Hematopoietic cell-derived microparticle tissue factor contributes to fibrin formation during thrombus propagation. Blood 2004, 104:3190-3197.
176. Furie B., Furie B.C. Mechanisms of thrombus formation. N Engl J Med 2008, 359:938-949.
177. Sachs U.J., Nieswandt B. In vivo thrombus formation in murine models. Circ Res 2007, 100:979-991.
178. Nergiz-Unal R., Cosemans J.M.E.M., Feijge M.A.H., van der Meijden P.E.J., Storey R.F., van Giezen J.J.J., et al. Stabilizing role of platelet P2Y(12) receptors in shear-dependent thrombus formation on ruptured plaques. PLoS One 2010, 5(4):e10130.
179. Reininger A.J., Bernlochner I., Penz S.M., Ravanat C., Smethurst P., Farndale R.W., et al. A 2-step mechanism of arterial thrombus formation induced by human atherosclerotic plaques. J Am Coll Cardiol 2010, 55:1147-1158.
180. Langer H.F., Gawaz M. Platelet-vessel wall interactions in atherosclerotic disease. Thromb Haemost 2008, 99:480-486.
181. Penz S.M., Reininger A.J., Toth O., Deckmyn H., Brandl R., Siess W. Glycoprotein Ibalpha inhibition and ADP receptor antagonists, but not aspirin, reduce platelet thrombus formation in flowing blood exposed to atherosclerotic plaques. Thromb Haemost 2007, 97:435-443.
182. Ruggeri Z.M. Platelets in atherothrombosis. Nat Med 2002, 8:1227-1234.
183. Cosemans J.M.E.M., Kuijpers M.J.E., Lecut C., Loubele S.T.B.G., Heeneman S., Jandrot-Perrus M., et al. Contribution of platelet glycoprotein VI to the thrombogenic effect of collagens in fibrous atherosclerotic lesions. Atherosclerosis 2005, 181:19-27.
184. Penz S., Reininger A.J., Brandl R., Goyal P., Rabie T., Bernlochner I., et al. Human atheromatous plaques stimulate thrombus formation by activating platelet glycoprotein VI. FASEB J 2005, 19:898-909.
185. Schulz C., Penz S., Hoffmann C., Langer H., Gillitzer A., Schneider S., et al. Platelet GPVI binds to collagenous structures in the core region of human atheromatous plaque and is critical for atheroprogression in vivo. Basic Res Cardiol 2008, 103:356-367.
186. Bluestein D., Niu L., Schoephoerster R.T., Dewanjee M.K. Fluid mechanics of arterial stenosis: relationship to the development of mural thrombus. Ann Biomed Eng 1997, 25:344-356.
187. Siegel J.M., Markou C.P., Ku D.N., Hanson S.R. A scaling law for wall shear rate through an arterial stenosis. J Biomech Eng 1994, 116:446-451.
188. Reininger A.J. Function of von Willebrand factor in haemostasis and thrombosis. Haemophilia 2008, 14(Suppl. 5):11-26.
189. Ruggeri Z.M. The role of von Willebrand factor in thrombus formation. Thromb Res 2007, 120(Suppl. 1):S5-S9.
190. Ruan C.H., So S.P., Ruan K.H. Inducible COX-2 dominates over COX-1 in prostacyclin biosynthesis: mechanisms of COX-2 inhibitor risk to heart disease. Life Sci 2011, 88:24-30.
191. McAdam B.F., Catella-Lawson F., Mardini I.A., Kapoor S., Lawson J.A., FitzGerald G.A. Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2. Proc Nat Acad Sci USA 1999, 96:272-277.
192. Cheng Y., Wang M., Yu Y., Lawson J., Funk C.D., FitzGerald G.A. Cyclooxygenases, microsomal prostaglandin E synthase-1, and cardiovascular function. J Clin Invest 2006, 116:1391-1399.
193. Narumiya S., Sugimoto Y., Ushikubi F. Prostanoid receptors: structures, properties, and functions. Physiol Rev 1999, 79:1193-1226.
194. Manganello J.M., Djellas Y., Borg C., Antonakis K., Le Breton G.C. Cyclic AMP-dependent phosphorylation of thromboxane A(2) receptor-associated Galpha(13). J Biol Chem 1999, 274:28003-28010.
195. Fabre J.E., Nguyen M., Athirakul K., Coggins K., McNeish J.D., Austin S., et al. Activation of the murine EP3 receptor for PGE2 inhibits cAMP production and promotes platelet aggregation. J Clin Invest 2001, 107:603-610.
196. Mao G.F., Jin J.G., Bastepe M., Ortiz-Vega S., Ashby B. Prostaglandin E2 both stimulates and inhibits adenyl cyclase on platelets: comparison of effects on cloned EP4 and EP3 prostaglandin receptor subtypes. Prostaglandins 1996, 52:175-185.
197. Iyu D., Glenn J.R., White A.E., Johnson A.J., Fox S.C., Heptinstall S. The role of prostanoid receptors in mediating the effects of PGE(2) on human platelet function. Platelets 2010, 21:329-342.
198. Topper J.N., Cai J., Falb D., Gimbrone M.A. Identification of vascular endothelial genes differentially responsive to fluid mechanical stimuli: cyclooxygenase-2, manganese superoxide dismutase, and endothelial cell nitric oxide synthase are selectively up-regulated by steady laminar shear stress. Proc Nat Acad Sci USA 1996, 93:10417-10422.
199. Caughey G.E., Cleland L.G., Gamble J.R., James M.J. Up-regulation of endothelial cyclooxygenase-2 and prostanoid synthesis by platelets. Role of thromboxane A2. J Biol Chem 2001, 276:37839-37845.
200. Rex S., Freedman N.J. Inhibition of platelet function by the endothelium. Platelets 2006, 251-279. Academic Press, San Diego, CA. A.D. Michelson (Ed.).
201. Gambaryan S., Kobsar A., Rukoyatkina N., Herterich S., Geiger J., Smolenski A., et al. Thrombin and collagen induce a feedback inhibitory signaling pathway in platelets involving dissociation of the catalytic subunit of protein kinase A from an NFkappaB-IkappaB complex. J Biol Chem 2010, 285:18352-18363.
202. Harbeck B., Huttelmaier S., Schluter K., Jockusch B.M., Illenberger S. Phosphorylation of the vasodilator-stimulated phosphoprotein regulates its interaction with actin. J Biol Chem 2000, 275:30817-30825.
203. Reinhard M., Jarchau T., Walter U. Actin-based motility: stop and go with Ena/VASP proteins. Trends Biochem Sci 2001, 26:243-249.
204. Aszodi A., Pfeifer A., Ahmad M., Glauner M., Zhou X.H., Ny L., et al. The vasodilator-stimulated phosphoprotein (VASP) is involved in cGMP- and cAMP-mediated inhibition of agonist-induced platelet aggregation, but is dispensable for smooth muscle function. EMBO J 1999, 18:37-48.
205. Schwarz U.R., Walter U., Eigenthaler M. Taming platelets with cyclic nucleotides. Biochem Pharmacol 2001, 62:1153-1161.
206. Cavallini L., Coassin M., Borean A., Alexandre A. Prostacyclin and sodium nitroprusside inhibit the activity of the platelet inositol 1,4,5-trisphosphate receptor and promote its phosphorylation. J Biol Chem 1996, 271:5545-5551.
207. Smyth E.M., Li W.H., FitzGerald G.A. Phosphorylation of the prostacyclin receptor during homologous desensitization. A critical role for protein kinase c. J Biol Chem 1998, 273:23258-23266.
208. Wilson S.J., Smyth E.M. Internalization and recycling of the human prostacyclin receptor is modulated through its isoprenylation-dependent interaction with the delta subunit of cGMP phosphodiesterase 6. J Biol Chem 2006, 281:11780-11786.
209. Murata T., Ushikubi F., Matsuoka T., Hirata M., Yamasaki A., Sugimoto Y., et al. Altered pain perception and inflammatory response in mice lacking prostacyclin receptor. Nature 1997, 388:678-682.
210. Cheng Y., Austin S.C., Rocca B., Koller B.H., Coffman T.M., Grosser T., et al. Role of prostacyclin in the cardiovascular response to thromboxane A2. Science 2002, 296:539-541.
211. Wise H., Wong Y.H., Jones R.L. Prostanoid signal integration and cross talk. Neurosignals 2002, 11:20-28.
212. Wilson S.J., Roche A.M., Kostetskaia E., Smyth E.M. Dimerization of the human receptors for prostacyclin and thromboxane facilitates thromboxane receptor-mediated cAMP generation. J Biol Chem 2004, 279:53036-53047.
213. Wilson S.J., Dowling J.K., Zhao L., Carnish E., Smyth E.M. Regulation of thromboxane receptor trafficking through the prostacyclin receptor in vascular smooth muscle cells: role of receptor heterodimerization. Arterioscler Thromb Vasc Biol 2007, 27:290-296.
214. Alderton W.K., Cooper C.E., Knowles R.G. Nitric oxide synthases: structure, function and inhibition. Biochem J 2001, 357:593-615.
215. Gkaliagkousi E., Ritter J., Ferro A. Platelet-derived nitric oxide signaling and regulation. Circ Res 2007, 101:654-662.
216. Naseem K.M. eNOS, iNOS or no NOS, that is the question. J Thromb Haemost 2008, 6:1373-1375.
217. Gambaryan S., Kobsar A., Hartmann S., Birschmann I., Kuhlencordt P.J., Muller-Esterl W., et al. NO-synthase-/NO-independent regulation of human and murine platelet soluble guanylyl cyclase activity. J Thromb Haemost 2008, 6:1376-1384.
218. Tymvios C., Moore C., Jones S., Solomon A., Sanz-Rosa D., Emerson M. Platelet aggregation responses are critically regulated in vivo by endogenous nitric oxide but not by endothelial nitric oxide synthase. Br J Pharmacol 2009, 158:1735-1742.
219. Moore C., Tymvios C., Emerson M. Functional regulation of vascular and platelet activity during thrombosis by nitric oxide and endothelial nitric oxide synthase. Thromb Haemost 2010, 104:342-349.
220. Dangel O., Mergia E., Karlisch K., Groneberg D., Koesling D., Friebe A. Nitric oxide-sensitive guanylyl cyclase is the only nitric oxide receptor mediating platelet inhibition. J Thromb Haemost 2010, 8:1343-1352.
221. Radomski M.W., Palmer R.M., Moncada S. An l-arginine/nitric oxide pathway present in human platelets regulates aggregation. Proc Nat Acad Sci USA 1990, 87:5193-5197.
222. Chung A.W., Jurasz P., Hollenberg M.D., Radomski M.W. Mechanisms of action of proteinase-activated receptor agonists on human platelets. Br J Pharmacol 2002, 135:1123-1132.
223. Antl M., von Bruhl M.L., Eiglsperger C., Werner M., Konrad I., Kocher T., et al. IRAG mediates NO/cGMP-dependent inhibition of platelet aggregation and thrombus formation. Blood 2007, 109:552-559.
224. Walter U, Gambaryan S. cGMP and cGMP-dependent protein kinase in platelets and blood cells. Handb Exp Pharmacol 2009533-48.
225. Roberts W., Riba R., Homer-Vanniasinkam S., Farndale R.W., Naseem K.M. Nitric oxide specifically inhibits integrin-mediated platelet adhesion and spreading on collagen. J Thromb Haemost 2008, 6:2175-2185.
226. Roberts W., Michno A., Aburima A., Naseem K.M. Nitric oxide inhibits von Willebrand factor-mediated platelet adhesion and spreading through regulation of integrin alpha(IIb)beta(3) and myosin light chain. J Thromb Haemost 2009, 7:2106-2115.
227. Blackmore P.F. Biphasic effects of nitric oxide on calcium influx in human platelets. Thromb Res 2011, 127(1):e8-e14.
228. Marjanovic J.A., Li Z., Stojanovic A., Du X. Stimulatory roles of nitric-oxide synthase 3 and guanylyl cyclase in platelet activation. J Biol Chem 2005, 280:37430-37438.
229. Rajendran S., Chirkov Y.Y. Platelet hyperaggregability: impaired responsiveness to nitric oxide ("platelet NO resistance") as a therapeutic target. Cardiovasc Drugs Ther 2008, 22:193-203.
230. Bergandi L., Cordero M., Anselmino M., Ferraro G., Ravera L., Dalmasso P., et al. Altered nitric oxide/cGMP platelet signaling pathway in platelets from patients with acute coronary syndromes. Clin Res Cardiol 2010, 99:557-564.
231. Lewandrowski U., Wortelkamp S., Lohrig K., Zahedi R.P., Wolters D.A., Walter U., et al. Platelet membrane proteomics: a novel repository for functional research. Blood 2009, 114:e10-e19.
232. Senis Y.A., Tomlinson M.G., Garcia A., Dumon S., Heath V.L., Herbert J., et al. A comprehensive proteomics and genomics analysis reveals novel transmembrane proteins in human platelets and mouse megakaryocytes including G6b-B, a novel immunoreceptor tyrosine-based inhibitory motif protein. Mol Cell Proteomics 2007, 6:548-564.
233. Moebius J., Zahedi R.P., Lewandrowski U., Berger C., Walter U., Sickmann A. The human platelet membrane proteome reveals several new potential membrane proteins. Mol Cell Proteomics 2005, 4:1754-1761.
234. Coppinger J.A., Cagney G., Toomey S., Kislinger T., Belton O., McRedmond J.P., et al. Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions. Blood 2004, 103:2096-2104.
235. Piersma S.R., Broxterman H.J., Kapci M., de Haas R.R., Hoekman K., Verheul H.M., et al. Proteomics of the TRAP-induced platelet releasate. J Proteomics 2009, 72:91-109.
236. Hernandez-Ruiz L., Valverde F., Jimenez-Nunez M.D., Ocana E., Saez-Benito A., Rodriguez-Martorell J., et al. Organellar proteomics of human platelet dense granules reveals that 14-3-3zeta is a granule protein related to atherosclerosis. J Proteome Res 2007, 6:4449-4457.
237. Della C.A., Maugeri N., Pampuch A., Cerletti C., de G.G., Rotilio D. Application of 2-dimensional difference gel electrophoresis (2D-DIGE) to the study of thrombin-activated human platelet secretome. Platelets 2008, 19:43-50.
238. Fong K.P., Barry C., Tran A.N., Traxler E.A., Wannemacher K.M., Tang H.Y., et al. Deciphering the human platelet sheddome. Blood 2010, 117(1):e15-e26.
239. Senzel L., Gnatenko D.V., Bahou W.F. The platelet proteome. Curr Opin Hematol 2009, 16:329-333.
240. Raab M., Daxecker H., Edwards R.J., Treumann A., Murphy D., Moran N. Protein interactions with the platelet integrin alpha(IIb) regulatory motif. Proteomics 2010, 10:2790-2800.
241. Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J., Schutz C., et al. Phosphoproteome of resting human platelets. J Proteome Res 2008, 7:526-534.
242. Goodall A.H., Burns P., Salles I., Macaulay I.C., Jones C.I., Ardissino D., et al. Transcription profiling in human platelets reveals LRRFIP1 as a novel protein regulating platelet function. Blood 2010, 116:4646-4656.
243. Macaulay I.C., Tijssen M.R., Thijssen-Timmer D.C., Gusnanto A., Steward M., Burns P., et al. Comparative gene expression profiling of in vitro differentiated megakaryocytes and erythroblasts identifies novel activatory and inhibitory platelet membrane proteins. Blood 2007, 109:3260-3269.
244. Watkins N.A., Gusnanto A., de B.B., De S., Miranda-Saavedra D., Hardie D.L., et al. A HaemAtlas: characterizing gene expression in differentiated human blood cells. Blood 2009, 113:e1-e9.
245. O'Connor M.N., Salles I.I., Cvejic A., Watkins N.A., Walker A., Garner S.F., et al. Functional genomics in zebrafish permits rapid characterization of novel platelet membrane proteins. Blood 2009, 113:4754-4762.
246. Senis Y.A., Antrobus R., Severin S., Parguina A.F., Rosa I., Zitzmann N., et al. Proteomic analysis of integrin alphaIIbbeta3 outside-in signaling reveals Src-kinase-independent phosphorylation of Dok-1 and Dok-3 leading to SHIP-1 interactions. J Thromb Haemost 2009, 7:1718-1726.
247. Garcia A., Prabhakar S., Hughan S., Anderson T.W., Brock C.J., Pearce A.C., et al. Differential proteome analysis of TRAP-activated platelets: involvement of DOK-2 and phosphorylation of RGS proteins. Blood 2004, 103:2088-2095.